The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Singhal et al., N Engl J Med 341(21):1565-1571 November 18, 1999.

Correction
PreviousPrevious
Volume 342:364 February 3, 2000 Number 5
NextNext

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

 

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by Singhal, S.
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma . On page 1565, the affiliations should have read as follows: "From the Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, Little Rock (S.S., J.M., R.D., D.A., P.R., P.E., N.M., E.A., C.W., J.Z., B.B.); and the Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York (M.D.)." Drs. Singhal and Mehta are currently affiliated with the Myeloma and Lymphoma Program, South Carolina Cancer Center, University of South Carolina.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.